335 related articles for article (PubMed ID: 30642281)
21. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
22. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients.
Muretto P; Ruzzo A; Pizzagalli F; Graziano F; Maltese P; Zingaretti C; Berselli E; Donnarumma N; Magnani M
Ann Oncol; 2008 Mar; 19(3):516-9. PubMed ID: 17986624
[TBL] [Abstract][Full Text] [Related]
23. THE STUDY OF THE EXPRESSION OF CDH1, KI67, P53 AND HER2 IN DIFFUSE GASTRIC CARCINOMA.
Muzashvili T; Tutisani A; Chabradze G; Beridze N; Museridze N
Georgian Med News; 2020 Feb; (299):147-150. PubMed ID: 32242863
[TBL] [Abstract][Full Text] [Related]
24. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
[TBL] [Abstract][Full Text] [Related]
25. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
27. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
[TBL] [Abstract][Full Text] [Related]
28. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
29. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
Graziano F; Humar B; Guilford P
Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
[TBL] [Abstract][Full Text] [Related]
30. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.
Nasri S; More H; Graziano F; Ruzzo A; Wilson E; Dunbier A; McKinney C; Merriman T; Guilford P; Magnani M; Humar B
BMC Cancer; 2008 May; 8():138. PubMed ID: 18482459
[TBL] [Abstract][Full Text] [Related]
31. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
[TBL] [Abstract][Full Text] [Related]
33. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
[TBL] [Abstract][Full Text] [Related]
34. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
[TBL] [Abstract][Full Text] [Related]
35. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer.
Pinheiro H; Bordeira-Carriço R; Seixas S; Carvalho J; Senz J; Oliveira P; Inácio P; Gusmão L; Rocha J; Huntsman D; Seruca R; Oliveira C
Hum Mol Genet; 2010 Mar; 19(5):943-52. PubMed ID: 19965908
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
37. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.
Nemtsova MV; Kalinkin AI; Kuznetsova EB; Bure IV; Alekseeva EA; Bykov II; Khorobrykh TV; Mikhaylenko DS; Tanas AS; Kutsev SI; Zaletaev DV; Strelnikov VV
Sci Rep; 2020 Jan; 10(1):504. PubMed ID: 31949278
[TBL] [Abstract][Full Text] [Related]
39. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
40. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
